Related Experiment Video
Updated: Aug 19, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Higher thymocyte selection-associated high mobility group box (TOX) expression predicts poor prognosis in patients
Sai Li1, Sifu Yang2, Yupeng Hong3
1Department of gynecologic oncology, Women's Hospital, Zhejiang University school of medicine, Hangzhou, China.
Background:
Ovarian cancer is one of the most lethal gynecologic malignancies with a dismal prognosis that poses a serious threat to human health, highlighting the need for more knowledge about what is required for identifying some biomarkers for early diagnosis, prediction of prognosis and disease monitoring. TOX, a critical transcription factor related to the development of malignancies that contributing to lymphocytes not just T cells, had been proved prognostic value in some spectrum of cancers. Here, we aimed to study the prognostic role of TOX in ovarian cancer.
Results:
We found that TOX was not only expressed in CD8 T cells but also tumor cells. TOX expression score was higher in ovarian cancer tissues and correlated with survival status. Survival analysis revealed that ovarian cancer patients with high TOX expression score generally shorter overall survival and disease-free survival times. Univariate and Multivariate Cox demonstrated that TOX expression score could be used as an independent prognostic factor for patients with ovarian cancer.
Conclusion:
TOX expression in ovarian cancer could be a promising tool for predict overall survival of ovarian cancer patients.
